Psychotic symptoms in methamphetamine users with and without cannabis
Part of Mental health clinical trials.
This study compares people who have psychosis from methamphetamine and also use cannabis with those who only have methamphetamine-induced psychosis. It aims to understand how cannabis may affect their symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with methamphetamine-induced psychotic disorder.
- You are between 18 and 64 years old.
- You have not taken any psychiatric medications for at least one month before the study starts.
- You agree to take part in the study and sign a consent form.
- You do not have other major health problems like high blood pressure, diabetes, kidney disease, heart disease, or certain autoimmune disorders.
- You do not have other psychiatric disorders (besides the methamphetamine psychosis) or alcohol use disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for patterns in psychiatric symptoms among people who have psychotic symptoms caused by methamphetamine use. You may qualify if you are 18-65, haven't taken psychiatric medication for at least a month, and do not have certain other health conditions.
This study looks at the electrical activity of the heart (ECG) in people who use methamphetamine, including those who develop psychosis from it. It compares them to healthy volunteers to see if methamphetamine affects heart function.
This study looks at two blood proteins (LRFN5 and OLFM4) in people with methamphetamine use disorder or methamphetamine-induced psychosis, compared to healthy controls. Results may help understand the biology of these conditions.
This study observes patients with psychosis to help tell if it is caused by schizophrenia or by methamphetamine use, so doctors can offer the right treatment.
This study uses brain imaging to understand how thinking works in people who use cannabis, comparing those with psychosis to people without psychosis. It may help researchers learn what brain patterns relate to thinking difficulties and how cannabis use fits in.
This trial studies how different strengths of cannabis affect the brain's white matter in people with early psychosis. It may help doctors understand which cannabis potencies are less harmful for young adults with psychosis.
Hear when a new Methamphetamine Induced Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.